Treatment of neovascular glaucoma by anti-vascular endothelial growth factor combined with ultrasonic ciliary plasty
10.3980/j.issn.1672-5123.2023.4.27
- VernacularTitle:抗VEGF联合超声睫状体成形术治疗新生血管性青光眼
- Author:
Yu-Hao WANG
1
;
Rui-Qian QIU
1
;
Tian-Tian QIANG
1
;
Meng-Yuan CHEN
1
;
Ai-Lian WANG
1
Author Information
1. Graduate School, Bengbu Medical College, Bengbu 233000, Anhui Province, China
- Publication Type:Journal Article
- Keywords:
ultrasonic ciliary plasty;
neovascular glaucoma;
anti-vascular endothelial growth factor(VEGF)
- From:
International Eye Science
2023;23(4):668-671
- CountryChina
- Language:Chinese
-
Abstract:
AIM: To investigate the clinical efficacy and safety of ultrasonic ciliary plasty(UCP)combined with injection of anti-vascular endothelial growth factor(VEGF)in the treatment of neovascular glaucoma(NVG).METHODS: A total of 30 NVG patients(30 eyes)admitted to the First Affiliated Hospital of Bengbu Medical College from September 2020 to September 2021 were selected. After admission, all the eyes of the patients were injected with anti-VEGF drug(ranibizumab). After surgery, 15 patients were randomly selected for UCP treatment(UCP group), and the other 15 patients received trabeculectomy(trabeculectomy group). During the 10mo postoperative follow-up, the decrease of intraocular pressure was compared between the two groups and the changes of the degree of ocular pain and the occurrence of related complications were evaluated at each follow-up visit.RESULTS: The intraocular pressure and pain degree of the UCP and trabeculectomy groups were significantly lower than those before operation, and the complication probability of the UCP group was less than that of the trabeculectomy group.CONCLUSION: With fewer complications and high safety, UCP combined with anti-VEGF injection can effectively control intraocular pressure and pain in NVG patients.
